Medical Device / Topical Scar Treatment
Pregnancy: Safe for topical use — no systemic absorption.
Silicone Gel / Sheeting (Scar Management)
Brand names: Mepiform, Cica-Care, Dermatix, NewGel+E
Adult dose
Dose: Silicone gel: apply thin layer to healed wound twice daily; silicone sheeting: apply for 12–24 hours/day; commence once epithelialisation complete and wound fully healed
Route: Topical
Frequency: Twice daily (gel) or continuously (sheeting — minimum 12 hours/day)
Max: Continuous use for 3–6 months minimum (scar maturation period)
First-line non-invasive scar treatment in burns — British Burns Association and NICE recommend as initial treatment for established/developing hypertrophic scars and keloids. Mechanism: hydration, temperature increase, and static electricity reduce collagen synthesis. Most effective when started early (2 weeks post-healing) and used consistently.
Paediatric dose
Route:
Frequency: 12–24 hours/day (sheeting); twice daily (gel)
Max: As per adult schedule
Safe in all paediatric age groups — commence as soon as wound is fully re-epithelialised. Paediatric burns scar treatment: silicone gel + compression garment combination is BBA standard of care.
Dose adjustments
Renal
Not applicable — topical use only.
Hepatic
Not applicable.
Clinical pearls
- BBA Scar Management Guidelines 2019: silicone therapy is Grade A evidence for hypertrophic scar prevention and treatment. Commence within 2 weeks of wound healing; use for minimum 3–6 months. Combine with compression garment (24–23 mmHg pressure) for burns covering joint surfaces
- Keloid vs hypertrophic scar distinction: hypertrophic scars remain within wound boundaries and may spontaneously regress; keloids extend beyond wound margins and rarely regress without treatment. Silicone effective for hypertrophic — less effective for established keloids which require additional intralesional therapy (triamcinolone, bleomycin, 5-FU, verapamil)
- Adherence is critical: 12–24 hours/day wear for 3–6 months is required for efficacy; poor adherence (common) leads to treatment failure. Silicone sheets can be washed and reused for 2–3 months before replacing. Gel formulation preferred for facial areas, joints, and paediatric patients
Contraindications
- Open or incompletely healed wounds (risk of maceration and delayed healing)
- Active infection at application site
- Known silicone allergy (rare)
Side effects
- Skin maceration (if wound not fully healed)
- Pruritus at application site
- Contact dermatitis (uncommon)
- Folliculitis (under sheeting — ensure daily cleaning)
- Malodour under sheeting (poor hygiene)
Interactions
- No pharmacological interactions — topical medical device
Monitoring
- Scar assessment (Vancouver Scar Scale or Patient and Observer Scar Assessment Scale — POSAS)
- Wound integrity under sheeting (daily skin check)
- Adherence to daily wear schedule
- Signs of contact dermatitis or folliculitis
Reference: BNFc; British Burns Association Scar Management Guidelines 2019; NICE NG24 (Burns); Mustoe et al. Plast Reconstr Surg 2002 (International Advisory Panel on Scar Management); BNFc. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- APACHE II Score · ICU Scoring
- SAPS II Score · ICU Severity Scoring
- NUTRIC Score for ICU Nutrition Risk · Nutrition
- Opioid Conversion / Equianalgesic Guide · Pain Management
- TISS-28 — Therapeutic Intervention Scoring System · ICU Workload
- Endotracheal Tube Depth and Tidal Volume Calculator · Airway Management